无创替代指标对Fontan循环患者肝纤维化的预测效果较差
该回顾性研究纳入45例Fontan循环病程至少10年的成人患者,评估瞬时弹性成像(TE)和增强肝纤维化(ELF)检测预测肝纤维化程度的价值。结果显示晚期肝纤维化占80.0%,TE和ELF评分在有或无晚期肝纤维化患者间无显著差异,而N末端脑钠肽前体和心室舒张末压较高。结论认为TE和ELF评分无法预测Fontan患者肝纤维化程度,肝活检仍是评估纤维化负荷的唯一有效方法。
要点
- 45例Fontan循环成人中晚期肝纤维化占80.0%。
- TE和ELF评分不能区分有无晚期肝纤维化。
- 肝活检仍是评估Fontan患者肝纤维化负荷的唯一有效方法。
核心结论
- TE和ELF评分无法预测Fontan循环患者的肝纤维化程度,肝活检仍是评估纤维化负荷的唯一有效方法。
研究设计与样本
- 回顾性研究,纳入45例Fontan循环病程至少10年的成人患者,均接受肝活检,分析纤维化分期与TE、ELF检测结果的关系。
主要发现
- 平均年龄25.9岁,平均Fontan病程20.8年,晚期肝纤维化见于36例(80.0%)患者。
- 有 versus 无晚期肝纤维化患者TE均值23.3 versus 24.8 kPa(P = .85),ELF评分均值8.94 versus 9.25(P = .44),均无显著差异。
- 有 versus 无晚期肝纤维化患者N末端脑钠肽前体均值224 versus 80 pg/mL(P < .01),心室舒张末压均值12 versus 9 mm Hg(P = .04),后者较高。
- 多因素分析未发现晚期肝纤维化的独立预测因子。
关键数值与推荐
- TE和ELF评分在有或无晚期肝纤维化患者间无显著差异。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Patients with Fontan circulation exhibit a high incidence of liver fibrosis and cirrhosis. Transient elastography (TE) and the enhanced liver fibrosis (ELF) test have proven useful as noninvasive surrogate markers of liver fibrosis for other chronic liver diseases. We evaluated whether TE and the ELF score can predict the degree of liver fibrosis in patients with Fontan circulation. METHODS: We retrospectively reviewed the medical records of 45 adult patients with at least 10 years of Fontan duration who had undergone liver biopsy and investigated the relation between the fibrosis stage and TE and the ELF test results. Additionally, the association of these variables and other biochemical and hemodynamic parameters was assessed. RESULTS: The mean age was 25.9 years and the mean Fontan duration was 20.8 years. Advanced liver fibrosis was present in 36 (80.0%) patients. TE or ELF score are comparable for patients with and without advanced liver fibrosis (mean 23.3 vs 24.8 kPa [P = .85] for TE; mean 8.94 vs 9.25 [P = .44] for the ELF score). However, N-terminal pro-brain natriuretic peptide level and ventricular end-diastolic pressure were higher in patients with advanced liver fibrosis (mean 224 vs 80 pg/mL [P < .01]; and mean 12 vs 9 mm Hg [P = .04], respectively). No independent predictor of advanced liver fibrosis was found in multivariate analysis. CONCLUSIONS: TE and the ELF score were unable to predict the degree of liver fibrosis in Fontan patients. Liver biopsy remains as the only valid method to assess fibrotic burden in this population.
引用
- Shin YR, Kim SU, Lee S, et al. Noninvasive surrogates are poor predictors of liver fibrosis in patients with Fontan circulation. J Thorac Cardiovasc Surg. 2021. PMID: 35034765. doi:10.1016/j.jtcvs.2021.12.028
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。